Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Jun 15, 2024 7:30pm
196 Views
Post# 36090819

RE:RE:The pharma possibility...

RE:RE:The pharma possibility...
riverrrow wrote: 45 million shares is way more shares than Roger has.  I can't see Roger giving up that kind of control.  $10 million is a wish list target.  Maybe there are one or two players willing to ante up a million or so, but Roger will want the placement spread out.  If Roger could raise $10 million it would help get all these new projects off the ground and hopefully raise the share price significantly.   GLTA.


Yep...Based on the small amounts of the prior raises, $10 million is quite the departure from the norm.  Why declare/wish for that high of an amount in a vacuum (no assurances) & then potentially fall miserably short?  I have to believe there must be a level of confidence/assurance within the company that there is at least a few million dollars already spoken for, possibly spread across two or more parties?  But having two or more outside parties willing to pitch in that amount (while not having more control/skin in the game) also seems to me to be a less likely scenario.  

Maybe there is/will be a well-funded biotech or smaller pharma who can pony up a portion of funds that would obviously be contingent on a structured partnership deal?  This would mitigate financial risk & leave the door open for future acquisition, licensing, etc. once a certain milestone(s) or development has been completed....just a lot of hope here for a win-win scenario & the best for all at stake. 

The potential alternative is we raise less (perhaps significantly less) than the company had hoped for & we continue to fiscally limp along from data readout to data readout or BTD.  The latter works great so long as you can continue to do it.  In this scenario, I would love to see a smallish raise (2 to 3 million) that gives up no control & comfortably gets us to the BTD stage, at which time a further raise &/or partnership should be much more attainable.  JMO.

<< Previous
Bullboard Posts
Next >>